Henry Ford Health System and Montfort (Mon4t), an Israeli startup specializing in neurological disorders, have launched a pilot study related to artificial intelligence (AI) and Parkinson's disease. In 2018, Mon4t was the winner of Henry Ford Innovations' first AI challenge. The multi-disciplinary team responsible for leveraging Henry Ford Health System's intellectual property, Henry Ford Innovations' AI challenge was part of its Global Technology Development Program in Israel.
As winner of the challenge award, Mon4t was granted $75,000 to support research and clinical development of its smartphone application, EncephaLog. EncephaLog, which is available for both Android and iOS devices, uses the smartphone's integral sensors (accelerometers, gyroscopes, and touchscreen) to record and analyze patient data from a panel of neurological tests. This information is processed through machine-learning paradigms and large datasets to answer some practical clinical questions. The app has two versions - one for use in the clinic by the patient's care team, and another version, with which patients can use their own smartphones to perform off-site evaluations.
In collaboration with Peter LeWitt, M.D., director of the Parkinson's Disease and Movement Disorders Program at Henry Ford Hospital, Mon4t has defined a new test module in EncephaLog for further assessment of treatments used for patients with Parkinson's disease.
Henry Ford Health System is one of the major U.S. centers for DBS therapy. With Montfort EncephaLog, timed tapping, gait recording, and other functions will gauge the impairment of movement, a core feature of Parkinson's disease.
Source:
https://www.news-medical.net/news/20191024/Mon4t-Henry-Ford-Health-System-jointly-launch-pilot-study-related-to-AI-and-Parkinsons-disease.aspx
No comments:
Post a Comment